FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025146267> ?p ?o ?g. }

• W3025146267 endingPage "1908" @default.
• W3025146267 startingPage "1897" @default.
• W3025146267 abstract "Bladder cancer is a lethal human malignancy. Currently, treatment for bladder cancer is limited. The anti-tumor effects of leflunomide have attracted much more concern in multiple human cancers.This study evaluated the anti-tumor effects of leflunomide on cell viability, colony formation, apoptosis, and cell cycle in two human bladder carcinoma cell lines, 5637 and T24. Meanwhile, the underlying mechanism including PI3K/Akt signaling pathway and autophagy modulation was also identified.Leflunomide markedly inhibited the growth of both bladder cancer cell lines and induced apoptosis and cell cycle arrest in S phase. The phosphorylation levels of Akt and P70S6K in both cell lines were significantly down-regulated with leflunomide treatment. Furthermore, the deceased formation of autophagosomes and the accumulation of LC3II and P62 suggested the blockade of autophagy by leflunomide. Modulation of autophagy with rapamycin and chloroquine markedly attenuated and enhanced the cytostatic effects of leflunomide, respectively.Leflunomide significantly reduced the cell viability of bladder cancer cells via inducing apoptosis and cell cycle arrest and suppressing the PI3K/Akt signaling pathway. In addition, the blockade of autophagy was observed, and autophagy inhibition enhanced leflunomide-mediating anti-tumor effects. Our data presented here offer novel ideas for comprehensive therapeutic regimes on bladder cancer." @default.
• W3025146267 created "2020-05-21" @default.
• W3025146267 creator A5019182050 @default.
• W3025146267 creator A5020389679 @default.
• W3025146267 creator A5053672435 @default.
• W3025146267 creator A5077684763 @default.
• W3025146267 creator A5079885983 @default.
• W3025146267 creator A5084027562 @default.
• W3025146267 date "2020-05-01" @default.
• W3025146267 modified "2023-10-01" @default.
• W3025146267 title "<p>Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells</p>" @default.
• W3025146267 cites W1271572098 @default.
• W3025146267 cites W1928265395 @default.
• W3025146267 cites W1964044051 @default.
• W3025146267 cites W1993637404 @default.
• W3025146267 cites W2000614504 @default.
• W3025146267 cites W2027511653 @default.
• W3025146267 cites W2040715737 @default.
• W3025146267 cites W2047977738 @default.
• W3025146267 cites W2052054022 @default.
• W3025146267 cites W2133708837 @default.
• W3025146267 cites W2146784451 @default.
• W3025146267 cites W2154147815 @default.
• W3025146267 cites W2156568495 @default.
• W3025146267 cites W2160699404 @default.
• W3025146267 cites W2172137514 @default.
• W3025146267 cites W2187241442 @default.
• W3025146267 cites W2339076888 @default.
• W3025146267 cites W2461774736 @default.
• W3025146267 cites W2550294854 @default.
• W3025146267 cites W2551865970 @default.
• W3025146267 cites W2586749844 @default.
• W3025146267 cites W2592487518 @default.
• W3025146267 cites W2763670669 @default.
• W3025146267 cites W2777388101 @default.
• W3025146267 cites W2790655699 @default.
• W3025146267 cites W2796148399 @default.
• W3025146267 cites W2800857805 @default.
• W3025146267 cites W2896506245 @default.
• W3025146267 cites W2947832884 @default.
• W3025146267 cites W4211115520 @default.
• W3025146267 doi "https://doi.org/10.2147/dddt.s252626" @default.
• W3025146267 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7244359" @default.
• W3025146267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32546957" @default.
• W3025146267 hasPublicationYear "2020" @default.
• W3025146267 type Work @default.
• W3025146267 sameAs 3025146267 @default.
• W3025146267 citedByCount "12" @default.
• W3025146267 countsByYear W30251462672021 @default.
• W3025146267 countsByYear W30251462672022 @default.
• W3025146267 countsByYear W30251462672023 @default.
• W3025146267 crossrefType "journal-article" @default.
• W3025146267 hasAuthorship W3025146267A5019182050 @default.
• W3025146267 hasAuthorship W3025146267A5020389679 @default.
• W3025146267 hasAuthorship W3025146267A5053672435 @default.
• W3025146267 hasAuthorship W3025146267A5077684763 @default.
• W3025146267 hasAuthorship W3025146267A5079885983 @default.
• W3025146267 hasAuthorship W3025146267A5084027562 @default.
• W3025146267 hasBestOaLocation W30251462671 @default.
• W3025146267 hasConcept C105696609 @default.
• W3025146267 hasConcept C121608353 @default.
• W3025146267 hasConcept C126322002 @default.
• W3025146267 hasConcept C185592680 @default.
• W3025146267 hasConcept C190283241 @default.
• W3025146267 hasConcept C203014093 @default.
• W3025146267 hasConcept C203522944 @default.
• W3025146267 hasConcept C2775905006 @default.
• W3025146267 hasConcept C2780352672 @default.
• W3025146267 hasConcept C2781059491 @default.
• W3025146267 hasConcept C29537977 @default.
• W3025146267 hasConcept C502942594 @default.
• W3025146267 hasConcept C53227056 @default.
• W3025146267 hasConcept C55493867 @default.
• W3025146267 hasConcept C62112901 @default.
• W3025146267 hasConcept C71924100 @default.
• W3025146267 hasConcept C75217442 @default.
• W3025146267 hasConcept C86554907 @default.
• W3025146267 hasConcept C96232424 @default.
• W3025146267 hasConcept C98274493 @default.
• W3025146267 hasConceptScore W3025146267C105696609 @default.
• W3025146267 hasConceptScore W3025146267C121608353 @default.
• W3025146267 hasConceptScore W3025146267C126322002 @default.
• W3025146267 hasConceptScore W3025146267C185592680 @default.
• W3025146267 hasConceptScore W3025146267C190283241 @default.
• W3025146267 hasConceptScore W3025146267C203014093 @default.
• W3025146267 hasConceptScore W3025146267C203522944 @default.
• W3025146267 hasConceptScore W3025146267C2775905006 @default.
• W3025146267 hasConceptScore W3025146267C2780352672 @default.
• W3025146267 hasConceptScore W3025146267C2781059491 @default.
• W3025146267 hasConceptScore W3025146267C29537977 @default.
• W3025146267 hasConceptScore W3025146267C502942594 @default.
• W3025146267 hasConceptScore W3025146267C53227056 @default.
• W3025146267 hasConceptScore W3025146267C55493867 @default.
• W3025146267 hasConceptScore W3025146267C62112901 @default.
• W3025146267 hasConceptScore W3025146267C71924100 @default.
• W3025146267 hasConceptScore W3025146267C75217442 @default.
• W3025146267 hasConceptScore W3025146267C86554907 @default.
• W3025146267 hasConceptScore W3025146267C96232424 @default.

• next